EBITDA rose 3% year-over-year to $149 million despite a 7% volume decline, with stable revenue and strong margin improvement. Guidance remains unchanged amid tariff uncertainty, and deleveraging continues, with net debt/EBITDA at 2.5x.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.